3451 PLANO PARKWAY, LEWISVILLE, TX
Orthofix Medical Inc. Updates Financial Outlook Following FDA Device Reclassi...
Reports First Quarter 2026 Results Highlighting Steady Execution Following Spine Commercial Channel Actions; Reaffirms Full-Year 2026 Financial Guidance
Realigns Spine Leadership to Strengthen Focus and Execution
Reports Fourth Quarter and Full-Year 2025 Financial Results and Provides 2026 Financial Guidance
Reports Third Quarter 2025 Financial Results
Reports Second Quarter 2025 Financial Results
News
Investor Presentation
Q1
FY 2025
Q3
Q2
FY 2024
S-3ASR
Registration Statement for Securities to be Offered to Employees
Definitive Proxy Statement
Additional Proxy Materials
Amended Schedule 13G - Ownership Report
Statement of Changes in Beneficial Ownership
Specialized Disclosure Report